Iranian Journal of Radiology

Published by: Neoscriber Demo Publisher
Crossmark
Uncorrected Proof scheduled for 16 (3)

Association of Non-Alcoholic Fatty Liver Disease with Increased Carotid Intima-Media Thickness Considering Other Cardiovascular Risk Factors

Ali Mohammadzadeh 1 , Vahid Shahkarami 2 , Madjid Shakiba 3 , Parto Sabetrasekh 3 and Maryam Mohammadzadeh 4 , *
Authors Information
1 Department of Radiology, Rajaie Cardiovascular and Medical Research Center, Iran University of Medical Sciences, Tehran, Iran
2 Iran University of Medical Sciences, Tehran, Iran
3 Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, Iran
4 Department of Radiology, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Radiology: In Press (In Press); e14260
  • Published Online: May 6, 2019
  • Article Type: Research Article
  • Received: May 29, 2017
  • Revised: March 19, 2019
  • Accepted: March 17, 2019
  • DOI: 10.5812/iranjradiol.14260

To Cite: Mohammadzadeh A, Shahkarami V, Shakiba M, Sabetrasekh P , Mohammadzadeh M. Association of Non-Alcoholic Fatty Liver Disease with Increased Carotid Intima-Media Thickness Considering Other Cardiovascular Risk Factors, Iran J Radiol. Online ahead of Print ; In Press(In Press):e14260. doi: 10.5812/iranjradiol.14260.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Rogha M, Najafi N, Azari A, Kaji M, Pourmoghaddas Z, Rajabi F, et al. Non-alcoholic steatohepatitis in a sample of Iranian adult population: Age is a risk factor. Int J Prev Med. 2011;2(1):24-7. [PubMed: 21448401]. [PubMed Central: PMC3063465].
  • 2. Sohrabpour A, Rezvan H, Amini-Kafiabad S, Dayhim M, Merat S, Pourshams A. Prevalence of Nonalcoholic Steatohepatitis in Iran: A Population based Study. Middle East J Dig Dis. 2010;2(1):14-9. [PubMed: 25197507]. [PubMed Central: PMC4154901].
  • 3. Crabb DW, Galli A, Fischer M, You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol. 2004;34(1):35-8. doi: 10.1016/j.alcohol.2004.07.005. [PubMed: 15670663].
  • 4. Machado M, Cortez-Pinto H. Non-alcoholic steatohepatitis and metabolic syndrome. Curr Opin Clin Nutr Metab Care. 2006;9(5):637-42. doi: 10.1097/01.mco.0000241677.40170.17. [PubMed: 16912563].
  • 5. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, et al. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol. 2003;18(5):588-94. doi: 10.1046/j.1440-1746.2003.02958.x. [PubMed: 12702052].
  • 6. Li H, Wang YJ, Tan K, Zeng L, Liu L, Liu FJ, et al. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat Dis Int. 2009;8(4):377-82. [PubMed: 19666406].
  • 7. Mencin AA, Lavine JE. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care. 2011;14(2):151-7. doi: 10.1097/MCO.0b013e328342baec. [PubMed: 21178608].
  • 8. McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol. 2006;40 Suppl 1:S17-29. doi: 10.1097/01.mcg.0000168645.86658.22. [PubMed: 16540762].
  • 9. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005;16(4):421-7. doi: 10.1097/01.mol.0000174153.53683.f2. [PubMed: 15990591].
  • 10. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191(2):235-40. doi: 10.1016/j.atherosclerosis.2006.08.021. [PubMed: 16970951].
  • 11. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43(4):413-27. doi: 10.1097/01.mpg.0000239995.58388.56. [PubMed: 17033514].
  • 12. Dogru T, Genc H, Tapan S, Ercin CN, Ors F, Aslan F, et al. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? Diabetes Res Clin Pract. 2012;96(1):47-52. doi: 10.1016/j.diabres.2011.11.022. [PubMed: 22189171].
  • 13. Pinto HC, Baptista A, Camilo ME, Valente A, Saragoca A, de Moura MC. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 1996;41(1):172-9. doi: 10.1007/BF02208601. [PubMed: 8565753].
  • 14. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11(1):74-80. doi: 10.1002/hep.1840110114. [PubMed: 2295475].
  • 15. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12(5):1106-10. doi: 10.1002/hep.1840120505. [PubMed: 2227807].
  • 16. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci. 2000;45(10):1929-34. doi: 10.1023/A:1005661516165. [PubMed: 11117562].
  • 17. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. 1995;36(3):437-41. doi: 10.1136/gut.36.3.437. [PubMed: 7698705]. [PubMed Central: PMC1382461].
  • 18. Schwimmer JB. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. Semin Liver Dis. 2007;27(3):312-8. doi: 10.1055/s-2007-985075. [PubMed: 17682977].
  • 19. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221-31. doi: 10.1056/NEJMra011775. [PubMed: 11961152].
  • 20. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009;50(4):1282-93. doi: 10.1002/hep.23119. [PubMed: 19637286]. [PubMed Central: PMC2757471].
  • 21. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28(1):27-38. doi: 10.1161/ATVBAHA.107.147538. [PubMed: 17690317].
  • 22. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care. 2006;29(6):1325-30. doi: 10.2337/dc06-0135. [PubMed: 16732016].
  • 23. Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med. 2005;22(10):1354-8. doi: 10.1111/j.1464-5491.2005.01646.x. [PubMed: 16176196].
  • 24. Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, Santorelli G, et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med. 2008;121(1):72-8. doi: 10.1016/j.amjmed.2007.08.041. [PubMed: 18187076].
  • 25. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341-50. doi: 10.1056/NEJMra0912063. [PubMed: 20879883].
  • 26. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113-21. doi: 10.1053/j.gastro.2005.04.014. [PubMed: 16012941].
  • 27. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865-73. doi: 10.1002/hep.21327. [PubMed: 17006923].
  • 28. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7(2):234-8. doi: 10.1016/j.cgh.2008.11.005. [PubMed: 19049831].
  • 29. Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2010;51(2):595-602. doi: 10.1002/hep.23314. [PubMed: 20014114].
  • 30. Ramilli S, Pretolani S, Muscari A, Pacelli B, Arienti V. Carotid lesions in outpatients with nonalcoholic fatty liver disease. World J Gastroenterol. 2009;15(38):4770-4. doi: 10.3748/wjg.15.4770. [PubMed: 19824109]. [PubMed Central: PMC2761553].
  • 31. Chen CH, Nien CK, Yang CC, Yeh YH. Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig Dis Sci. 2010;55(6):1752-60. doi: 10.1007/s10620-009-0935-9. [PubMed: 19688595].
  • 32. Taheri MS, Haghighatkhah H, Tash MH, Bakhshian R, Shakiba M, Jalali A. [The prevalence of carotid artery disease in candidates of coronary artery bypass graft]. Iran J Radiol. 2006;3(4). Persian.
  • 33. Antonini-Canterin F, Leiballi E, Capanna M, Burelli C, Cassin M, Macor F, et al. Association between carotid and coronary artery disease in patients with aortic valve stenosis: An angiographic study. Angiology. 2009;60(5):596-600. doi: 10.1177/0003319708327646. [PubMed: 19049997].
  • 34. Mortaz Hejri S, Mostafazadeh Davani B, Sahraian MA. Carotid endarterectomy for carotid stenosis in patients selected for coronary artery bypass graft surgery. Cochrane Database Syst Rev. 2009;(4). CD006074. doi: 10.1002/14651858.CD006074.pub2. [PubMed: 19821353].
  • 35. Shirani S, Boroumand MA, Abbasi SH, Maghsoodi N, Shakiba M, Karimi A, et al. Preoperative carotid artery screening in patients undergoing coronary artery bypass graft surgery. Arch Med Res. 2006;37(8):987-90. doi: 10.1016/j.arcmed.2006.06.001. [PubMed: 17045115].
  • 36. Ascher E, Hingorani A, Yorkovich W, Ramsey PJ, Salles-Cunha S. Routine preoperative carotid duplex scanning in patients undergoing open heart surgery: is it worthwhile? Ann Vasc Surg. 2001;15(6):669-78. doi: 10.1007/s10016-001-0088-6. [PubMed: 11769149].
  • 37. Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis. 2009;204(2):521-5. doi: 10.1016/j.atherosclerosis.2008.09.012. [PubMed: 18947828].
  • 38. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340(1):14-22. doi: 10.1056/NEJM199901073400103. [PubMed: 9878640].
  • 39. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96(5):1432-7. doi: 10.1161/01.CIR.96.5.1432. [PubMed: 9315528].
  • 40. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation. 2007;115(4):459-67. doi: 10.1161/CIRCULATIONAHA.106.628875. [PubMed: 17242284].
  • 41. Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J, et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol. 2005;11(12):1848-53. doi: 10.3748/wjg.v11.i12.1848. [PubMed: 15793879]. [PubMed Central: PMC4305889].
  • 42. Jepsen P, Vilstrup H, Mellemkjaer L, Thulstrup AM, Olsen JH, Baron JA, et al. Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study. Hepatogastroenterology. 2003;50(54):2101-4. [PubMed: 14696473].
  • 43. Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;129(1):375-8. doi: 10.1053/j.gastro.2005.05.041. [PubMed: 16012969].
  • 44. Valentina VN, Marijan B, Chedo D, Branka K. Subclinical hypothyroidism and risk to carotid atherosclerosis. Arq Bras Endocrinol Metabol. 2011;55(7):475-80. doi: 10.1590/S0004-27302011000700007. [PubMed: 22147096].
  • 45. Chiche F, Jublanc C, Coudert M, Carreau V, Kahn JF, Bruckert E. Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients. Atherosclerosis. 2009;203(1):269-76. doi: 10.1016/j.atherosclerosis.2008.06.011. [PubMed: 18649881].
  • 46. Caldwell SH, Crespo DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol. 2004;40(4):578-84. doi: 10.1016/j.jhep.2004.02.013. [PubMed: 15030972].
  • 47. Fahimi F, Shafiee K, Ahmadi J, Mehrabian M, Pezeshki E, Dehgani A. [Relationship between non alcoholic fatty liver disease with hemodynamic indexes of intracranial cerebral vessels in transcranial doppler ultrasound]. J Rafsanjan Univ Med Sci Health Serv. 2013;11(6):567-74. Persian.
  • 48. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998;47(5):699-713. doi: 10.2337/diabetes.47.5.699. [PubMed: 9588440].
  • 49. Bahrami H, Daryani NE, Mirmomen S, Kamangar F, Haghpanah B, Djalili M. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol. 2003;3:27. doi: 10.1186/1471-230X-3-27. [PubMed: 14561231]. [PubMed Central: PMC270051].
  • 50. Tarantino G, Finelli C, Colao A, Capone D, Tarantino M, Grimaldi E, et al. Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase? J Transl Med. 2012;10:50. doi: 10.1186/1479-5876-10-50. [PubMed: 22424154]. [PubMed Central: PMC3342159].
  • 51. Sert A, Aypar E, Pirgon O, Yilmaz H, Odabas D, Tolu I. Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. Am J Cardiol. 2013;112(3):436-43. doi: 10.1016/j.amjcard.2013.03.056. [PubMed: 23642511].
  • 52. Jarvisalo MJ, Jartti L, Nanto-Salonen K, Irjala K, Ronnemaa T, Hartiala JJ, et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation. 2001;104(24):2943-7. doi: 10.1161/hc4901.100522. [PubMed: 11739310].
  • 53. Manco M, Bedogni G, Monti L, Morino G, Natali G, Nobili V. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis. 2010;209(2):463-8. doi: 10.1016/j.atherosclerosis.2009.10.014. [PubMed: 19897197].
  • 54. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650-6. doi: 10.1056/NEJM199806043382302. [PubMed: 9614255].
  • 55. Durand DJ, Perler BA, Roseborough GS, Grega MA, Borowicz LM, Jr, Baumgartner WA, et al. Mandatory versus selective preoperative carotid screening: a retrospective analysis. Ann Thorac Surg. 2004;78(1):159-66. discussion 159-66. doi: 10.1016/j.athoracsur.2004.02.024. [PubMed: 15223422].
  • 56. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 1988;95(4):1056-62. doi: 10.1016/0016-5085(88)90183-7. [PubMed: 3410220].
  • 57. Caserta CA, Pendino GM, Amante A, Vacalebre C, Fiorillo MT, Surace P, et al. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy. Am J Epidemiol. 2010;171(11):1195-202. doi: 10.1093/aje/kwq073. [PubMed: 20457571].
  • 58. Roitberg GE, Sharkhun OO, Ushakova TI. [Non-alcoholic fatty liver disease as an atherosclerosis risk factor]. Eksp Klin Gastroenterol. 2010;(7):20-4. [PubMed: 21033079].
  • 59. Vlachopoulos C, Manesis E, Baou K, Papatheodoridis G, Koskinas J, Tiniakos D, et al. Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: A pilot study. Am J Hypertens. 2010;23(11):1183-9. doi: 10.1038/ajh.2010.144. [PubMed: 20634799].
  • 60. Karakurt F, Carlioglu A, Koktener A, Ozbek M, Kaya A, Uyar ME, et al. Relationship between cerebral arterial pulsatility and carotid intima media thickness in diabetic and non-diabetic patients with non-alcoholic fatty liver disease. J Endocrinol Invest. 2009;32(1):63-8. doi: 10.1007/BF03345681. [PubMed: 19337018].
  • 61. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review. J Hepatol. 2008;49(4):600-7. doi: 10.1016/j.jhep.2008.06.012. [PubMed: 18672311].
  • 62. Akin L, Kurtoglu S, Yikilmaz A, Kendirci M, Elmali F, Mazicioglu M. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation. Acta Paediatr. 2013;102(3):e107-13. doi: 10.1111/apa.12099. [PubMed: 23190373].
  • 63. Chavez-Tapia NC, Lizardi-Cervera J, Perez-Bautista O, Ramos-Ostos MH, Uribe M. Smoking is not associated with nonalcoholic fatty liver disease. World J Gastroenterol. 2006;12(32):5196-200. doi: 10.3748/wjg.v12.i32.5196. [PubMed: 16937532]. [PubMed Central: PMC4088019].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments